Woman's World on MSN1d
Can Neuropathy Be Reversed? See the Best Treatments for Nerve Pain
But when your peripheral nerves-those found outside of the brain and spinal cord-are damaged, it can cause pain and numbness ...
Neuropathic pain drugs linked to higher hip fracture risk in seniors
A new study by Monash University medicine safety experts found the use of gabapentinoids—medicines widely used to treat ...
Sangamo gets FDA clearance of IND application for ST-503 in iSFN
Sangamo Therapeutics announced that the FDA has cleared the investigational new drug application for its ST-503 program, an investigational epigenetic regul ...
A new discovery about pain signaling may contribute to better treatment of chronic pain
When pain signals are passed along the nervous system, proteins called calcium channels play a key role. Researchers at ...
Science Daily5d
Neuropathic pain drugs found to increase risk of hip fracture in older adults
A new study by medicine safety experts found the use of gabapentinoids -- medicines widely used to treat neuropathic pain -- increased the risk of hip fractures, especially in older patients who were ...
Orthopedics This Week5d
3- and 6-Month RCT Data for Novel Nerve Stim Treatment
The resulting paper, “ Clinical study of a micro-implantable pulse generator for the treatment of peripheral neuropathic pain ...
GlobalData on MSN11d
Averitas completes recruitment for trial of QUTENZA to treat post-surgical pain
Averitas Pharma, the US subsidiary of Grünenthal, has completed patient recruitment for the Phase III AV001 clinical study, ...
verywellhealth3d
When Should You Worry About Calf Pain? (and What to Do Next)
If you experience severe or sudden calf pain or suddenly have trouble moving or walking, it’s time to contact a healthcare ...
EurekAlert!7d
Light-based therapy reduces pain associated with peripheral diabetic neuropathy, study proves
The study was conducted at the Federal University of São Paulo and involved 144 diabetic patients, who were treated with ...
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain
Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...
Business Wire1d
Contineum Therapeutics Expands Clinical Development of PIPE-791 With FDA Authorization of Its Investigational New Drug (IND) Application for Chronic Pain
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...
EurekAlert!2d
A new discovery about pain signalling may contribute to better treatment of chronic pain
When pain signals are passed along the nervous system, proteins called calcium channels play a key role. Researchers at ...